
Tilray Brands, Canopy Growth, and Aurora Cannabis are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business involves the cannabis plant or the broader marijuana industry—this includes growers, processors, retailers, cannabinoid product manufacturers, biotech firms developing cannabis-based medicines, and ancillary service providers. For investors, these stocks can offer high growth potential but are typically volatile and heavily influenced by changing regulation, legal risk, and shifting consumer and medical markets, so they require careful due diligence. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
Aurora Cannabis (ACB)
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read Our Latest Research Report on ACB
Further Reading
- MarketBeat’s Top Five Stocks to Own in October 2025
- Alphabet Crushes Q3 Earnings, Reports First $100 Billion Quarter
- Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?
- CrowdStrike at All-Time High: Still a Buy, or Time to Trim?
- NVIDIA: The FOMO Melt-Up Could Reach a $7 Trillion Market Cap
- Broadcom: The Hidden Winner in Google’s Anthropic Chip Deal?
